Identification and Characterization of SNP Mutation in Genes related to Non-small cell lung cancer

Neelambika B. Hiremath, Dayananda P
{"title":"Identification and Characterization of SNP Mutation in Genes related to Non-small cell lung cancer","authors":"Neelambika B. Hiremath, Dayananda P","doi":"10.2174/1574362415999200819202218","DOIUrl":null,"url":null,"abstract":"\n\n The advent of Next Generation Sequencing (NGS) has created a high throughput\nplatform, to identify disease traits and phenotypic characteristics using RNASeq Sequencing analysis in humans. Non-small\ncell lung cancer (NSCLC), a lethal disease accounts for 85 percent of most lung cancers with very small window ofsurvival\nrate. The decision of tumour image bio marker impression can be improved by gene profile. Hence there is a need to\ncharacterise the variants in the disease manifestation.\n\n\n\nTo understand the SNP’s in the major genes responsible for NSCLC, RNASeq data of patients aged above 50\nyears, were downloaded from SRA database. The quality matrix analysis is mapped to Genome reference consortium human\nbuild 38 (GRCh38) to call the variants and identify SNP’s with the tuxedo protocol.\n\n\n\n The SNP’s and the patterns of variants were analysed to see the comparison between healthy individual and NSCLC\npatients, and in between patients of different age. Oncogenes commonly associated with the NSCLC like KRAS, EGFR,\nALK, BRAF and HER2 were mainly analysed to see the SNP’s and their characterisations with respect to the functional\nchange was done.\n\n\n\n The SNP’s with the greater quality scores belonging to the above said genes were identified which gives us a\nbaseline to understand the NSCLC at the Genomic level. Further fold change of these genes to the frequency of variant can\nbe mapped to understand the NSCLC at a greater depth.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574362415999200819202218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

The advent of Next Generation Sequencing (NGS) has created a high throughput platform, to identify disease traits and phenotypic characteristics using RNASeq Sequencing analysis in humans. Non-small cell lung cancer (NSCLC), a lethal disease accounts for 85 percent of most lung cancers with very small window ofsurvival rate. The decision of tumour image bio marker impression can be improved by gene profile. Hence there is a need to characterise the variants in the disease manifestation. To understand the SNP’s in the major genes responsible for NSCLC, RNASeq data of patients aged above 50 years, were downloaded from SRA database. The quality matrix analysis is mapped to Genome reference consortium human build 38 (GRCh38) to call the variants and identify SNP’s with the tuxedo protocol. The SNP’s and the patterns of variants were analysed to see the comparison between healthy individual and NSCLC patients, and in between patients of different age. Oncogenes commonly associated with the NSCLC like KRAS, EGFR, ALK, BRAF and HER2 were mainly analysed to see the SNP’s and their characterisations with respect to the functional change was done. The SNP’s with the greater quality scores belonging to the above said genes were identified which gives us a baseline to understand the NSCLC at the Genomic level. Further fold change of these genes to the frequency of variant can be mapped to understand the NSCLC at a greater depth.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非小细胞肺癌相关基因SNP突变的鉴定与鉴定
下一代测序(NGS)的出现创造了一个高通量平台,可以使用RNASeq测序分析来识别人类的疾病特征和表型特征。非小细胞性癌症(NSCLC)是一种致死性疾病,占大多数肺癌的85%,存活窗口很小。基因图谱可以改善肿瘤图像生物标记印象的判断。因此,有必要描述疾病表现中的变异。为了了解导致NSCLC的主要基因中的SNP,从SRA数据库下载了50岁以上患者的RNASeq数据。质量矩阵分析被映射到基因组参考联盟人构建38(GRCh38),以调用变体并用燕尾服方案识别SNP。分析了SNP和变异模式,以了解健康个体和NSCLC患者之间以及不同年龄患者之间的比较。主要分析了与NSCLC相关的癌基因,如KRAS、EGFR、ALK、BRAF和HER2,以了解SNP,并对其功能变化进行了表征。鉴定出属于上述基因的质量分数较高的SNP,这为我们在基因组水平上理解NSCLC提供了基础。这些基因对变异频率的进一步折叠变化可以被定位,以更深入地了解NSCLC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
18
审稿时长
>12 weeks
期刊介绍: In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.
期刊最新文献
Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma Antidiabetic Advancements In Silico: Pioneering Novel Heterocyclic Derivatives through Computational Design Exploring Squalene's Impact on Epidermal Thickening and Collagen Production: Molecular Docking Insights Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential Atrial Natriuretic Peptide as a Biomarker and Therapeutic Target in Cancer: A Focus on Colorectal Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1